UPDATE: Public Meeting – Reauthorization of MDUFA for 2023-2027

The U.S. Food and Drug Administration (FDA) is taking the necessary steps to ensure the agency is prepared to continue its vital public health mission in the event that our day-to-day operations are impacted by the COVID-19 public health emergency. We are exploring whether the April 7, 2020 public meeting to discuss proposed recommendations for the reauthorization of the Medical Device User Fee Amendments (MDUFA) for fiscal years 2023 through 2027 can be held via webcast only. Interested participants may continue to register and, if applicable, specify that they would like to present during the public comment session or in a specific session.

Learn More and Register

We will continue to provide updates as additional details become available. Questions? If you have questions about this public workshop, email CDRHPublicMeetings@fda.hhs.gov